171 related articles for article (PubMed ID: 32307006)
21. Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea.
Joh JS; Hong HC; Jeong IA; Chin BS; Yang HJ; Choi H; Bang JH
J Korean Med Sci; 2012 Oct; 27(10):1143-6. PubMed ID: 23091309
[TBL] [Abstract][Full Text] [Related]
22. The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort.
Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
Infect Dis Poverty; 2016 Nov; 5(1):96. PubMed ID: 27802839
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study.
do Prado TN; Miranda AE; de Souza FM; Dias Edos S; Sousa LK; Arakaki-Sanchez D; Sanchez MN; Golub JE; Maciel EL
BMC Infect Dis; 2014 Jul; 14():415. PubMed ID: 25066655
[TBL] [Abstract][Full Text] [Related]
24. The relationship between morning serum cortisol and the short ACTH test in the evaluation of adrenal insufficiency.
Lee MT; Won JG; Lee TI; Yang HJ; Lin HD; Tang KT
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):580-7. PubMed ID: 12636203
[TBL] [Abstract][Full Text] [Related]
25. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
[TBL] [Abstract][Full Text] [Related]
26. Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction.
Robertson KR; Oladeji B; Jiang H; Kumwenda J; Supparatpinyo K; Campbell TB; Hakim J; Tripathy S; Hosseinipour MC; Marra CM; Kumarasamy N; Evans S; Vecchio A; La Rosa A; Santos B; Silva MT; Montano S; Kanyama C; Firnhaber C; Price R; Marcus C; Berzins B; Masih R; Lalloo U; Sanne I; Yosief S; Walawander A; Nair A; Sacktor N; Hall C;
Clin Infect Dis; 2019 May; 68(10):1739-1746. PubMed ID: 30137250
[TBL] [Abstract][Full Text] [Related]
27. Characterizing Pediatric Tuberculosis with and without Human Immunodeficiency Virus Coinfection in Harare, Zimbabwe.
Earley M; Chirenda J; Highet A; Mujuru HA; Yang Z
Am J Trop Med Hyg; 2018 Sep; 99(3):601-607. PubMed ID: 30014829
[TBL] [Abstract][Full Text] [Related]
28. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study.
Mekonnen D; Derbie A; Desalegn E
BMC Res Notes; 2015 Nov; 8():666. PubMed ID: 26559922
[TBL] [Abstract][Full Text] [Related]
29. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
[TBL] [Abstract][Full Text] [Related]
30. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
[TBL] [Abstract][Full Text] [Related]
32. The role of social determinants on tuberculosis/HIV co-infection mortality in southwest Ethiopia: a retrospective cohort study.
Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
BMC Res Notes; 2016 Feb; 9():89. PubMed ID: 26868489
[TBL] [Abstract][Full Text] [Related]
33. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
Tanue EA; Nsagha DS; Njamen TN; Assob NJC
PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
[TBL] [Abstract][Full Text] [Related]
35. A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?
Berhan A; Berhan Y; Yizengaw D
Ethiop J Health Sci; 2013 Nov; 23(3):271-82. PubMed ID: 24307827
[TBL] [Abstract][Full Text] [Related]
36. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.
Nakiyingi L; Bwanika JM; Kirenga B; Nakanjako D; Katabira C; Lubega G; Sempa J; Nyesiga B; Albert H; Manabe YC
PLoS One; 2013; 8(9):e74023. PubMed ID: 24040151
[TBL] [Abstract][Full Text] [Related]
37. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L
Glob Health Action; 2015; 8():25964. PubMed ID: 25623609
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology, drug susceptibility and economic aspects of tuberculosis in Mubende district, Uganda.
Muwonge A; Malama S; Johansen TB; Kankya C; Biffa D; Ssengooba W; Godfroid J; Djønne B; Skjerve E
PLoS One; 2013; 8(5):e64745. PubMed ID: 23741382
[TBL] [Abstract][Full Text] [Related]
39. Association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients.
Mishkin K; Alaei K; Alikeyeva E; Paynter C; Aringazina A; Alaei A
J Glob Antimicrob Resist; 2018 Sep; 14():104-108. PubMed ID: 29496619
[TBL] [Abstract][Full Text] [Related]
40. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
